揭示修改细胞死亡模型对低分离辐射疗法疗效的影响
I R Sagov1,2, A A Sorokina1, E S Sukhikh1,3
1National Research Tomsk Polytechnic University, Lenin Avenue, 30, Tomsk, Russia.
Biomedical physics & engineering express
|October 7, 2025
概括
线性二次 (LQ) 模型高估了在低分量的辐射剂量. 像MLQ这样的修改模型更准确地评估2Gy分数 (EQD2) 的等效剂量,特别是在低α/β值的瘤中.
科学领域:
- 辐射瘤学 辐射瘤学
- 放射生物学的放射生物学
- 医学物理 医学物理
背景情况:
- 线性二次 (LQ) 模型是估计生物有效剂量 (BED) 和2 Gy分数 (EQD2) 的等效剂量的标准.
- 它对低分离的适用性受到争议,需要对替代模型进行评估.
研究的目的:
- 将LQ模型与其他放射生物模型 (MLQ,LQL,USC,PLQ) 进行比较.
- 评估它们在各种低分离方案中预测EQD2的充分性.
- 对前列腺癌和头癌的临床结果进行模型性能评估.
主要方法:
- 五种放射生物模型 (LQ,MLQ,LQL,USC,PLQ) 的瘤控制概率 (TCP) 和EQD2预测的比较.
- 分析已公布的临床结果 (局部控制,存活率),以确定等效的分成方案.
- 通过将计算的EQD2和TCP值与临床数据进行比较来评估模型.
主要成果:
- 修改后的放射生物模型表明,LQ模型在低分化中高估了剂量.
- 根据瘤部位,LQ模型的适用性限制有所不同:前列腺4.3 Gy,头部和部SCC8.5 Gy.
- 模型的准确性受到瘤α/β值的影响.
结论:
- 在低分化中,LQ模型的适用性取决于瘤的α/β值.
- 修改后的线性方程 (MLQ) 模型是由于其参数效率和稳定性而是一种切实可行的替代方案.
- 修改模型需要进一步的临床验证,以优化瘤控制并最大限度地减少正常组织的毒性.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.7K
07:08Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis
Published on: August 31, 2022
2.0K
相关概念视频
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K